Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2001. Start Trial.
Date Value
October 02, 2026 4.062
October 01, 2026 4.075
September 30, 2026 4.160
September 29, 2026 4.262
September 28, 2026 4.292
September 25, 2026 4.253
September 24, 2026 4.288
September 23, 2026 4.293
September 22, 2026 4.381
September 21, 2026 4.412
September 18, 2026 4.337
September 17, 2026 4.41
September 16, 2026 4.344
September 15, 2026 4.319
September 14, 2026 4.323
September 11, 2026 4.157
September 10, 2026 4.156
September 09, 2026 4.200
September 08, 2026 4.192
September 04, 2026 4.309
September 03, 2026 4.394
September 02, 2026 4.356
September 01, 2026 4.375
August 31, 2026 4.34
August 28, 2026 4.389
Date Value
August 27, 2026 4.342
August 26, 2026 4.442
August 25, 2026 4.497
August 24, 2026 4.472
August 21, 2026 4.527
August 20, 2026 4.488
August 19, 2026 4.567
August 18, 2026 4.418
August 17, 2026 4.343
August 14, 2026 4.277
August 13, 2026 4.357
August 12, 2026 4.344
August 11, 2026 4.396
August 10, 2026 4.505
August 07, 2026 4.574
August 06, 2026 4.506
August 05, 2026 4.444
August 04, 2026 4.451
August 03, 2026 4.449
July 31, 2026 4.464
July 30, 2026 4.497
July 29, 2026 4.596
July 28, 2026 4.639
July 27, 2026 4.489
July 24, 2026 4.435

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AstraZeneca PLC 10.28
Johnson & Johnson 7.256
Eli Lilly & Co. 31.76
Merck & Co., Inc. 8.495
Novo Nordisk A/S 4.875

Price to Book Value Related Metrics